NCT06921655

Brief Summary

The TEMA study (Targeting prEssure-Muscle-index to avoid ventilatory over-Assistance during pressure support ventilation) is a prospective, interventional crossover trial investigating the relationship between pressure support (PS) and tidal volume (Vt) in ICU patients with acute hypoxemic respiratory failure (AHRF) receiving pressure support ventilation (PSV). The study aims to assess whether the Pressure-Muscle Index (PMI)-a marker derived from the difference between plateau and peak inspiratory pressure-can help identify the optimal level of ventilatory assistance, preventing over-assistance and its associated complications such as diaphragm atrophy and patient self-inflicted lung injury (P-SILI). By exploring the sigmoidal relationship between PS and Vt, the study seeks to define a physiological threshold (PMI=0) that may serve as a personalized target for PSV titration.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
11mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Oct 2025Apr 2027

First Submitted

Initial submission to the registry

March 11, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 10, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

October 8, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2027

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

1.5 years

First QC Date

March 11, 2025

Last Update Submit

January 30, 2026

Conditions

Keywords

Pressure SupportTidal VolumeAcute Hypoxemic Respiratory Failure

Outcome Measures

Primary Outcomes (1)

  • Pressure Support-Tidal Volume (PS-Vt) Relationship

    The primary aim is to determine whether the PS-Vt curve exhibits a flat region (where tidal volume remains stable) before transitioning into a steep, compliance-dependent increase at higher PS levels. This transition point, identified as PSPMI=0, is hypothesized to represent the threshold for over-assistance.

    Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1)

Secondary Outcomes (11)

  • Validation of Pressure-Muscle Index (PMI) as an Over-Assistance Marker

    Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1) and during follow-up assessment on Days 4-6 (if patient remains intubated)

  • Impact of Respiratory Mechanics on PS-Vt Relationship

    During the interventional phase on Day 1 and during follow-up assessment on Days 4-6 (if patient remains intubated)

  • Rate of Ineffective Efforts During Over-Assistance

    Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1) and during follow-up assessment on Days 4-6 (if patient remains intubated)

  • Effect of Over-Assistance on Ventilatory Asynchronies

    Up to 5 minutes after each PS level adjustment during the interventional phase (Day 1) and during follow-up assessment on Days 4-6 (if patient remains intubated)

  • Weaning failure

    Up to 100 months or until the of death from any cause, whichever came first.

  • +6 more secondary outcomes

Study Arms (7)

Pressure Support PMI=0

EXPERIMENTAL

The PS level at which PMI is zeroed, meaning the patient's inspiratory effort contributes minimally to tidal volume

Procedure: Variation of Pressure Support Levels

Pressure Support +2

EXPERIMENTAL

Above PSPMI=0: +2 cmH₂O above PSPMI=0 (over-assistance zone).

Procedure: Variation of Pressure Support Levels

Pressure Support +4

EXPERIMENTAL

Above PSPMI=0: +4 cmH₂O above PSPMI=0 (over-assistance zone).

Procedure: Variation of Pressure Support Levels

Pressure Support +6

EXPERIMENTAL

Above PSPMI=0: +6 cmH₂O above PSPMI=0 (over-assistance zone).

Procedure: Variation of Pressure Support Levels

Pressure Support -2

EXPERIMENTAL

Below PSPMI=0: -2 cmH₂O below PSPMI=0 (under-assistance zone).

Procedure: Variation of Pressure Support Levels

Pressure Support -4

EXPERIMENTAL

\- Below PSPMI=0: -4 cmH₂O below PSPMI=0 (under-assistance zone).

Procedure: Variation of Pressure Support Levels

Pressure Support -6

EXPERIMENTAL

\- Below PSPMI=0: -6 cmH₂O below PSPMI=0 (under-assistance zone).

Procedure: Variation of Pressure Support Levels

Interventions

Patients will undergo six randomized PS levels (+2, +4, +6 cmH₂O above and -2, -4, -6 cmH₂O below PSPMI=0).

Pressure Support +2Pressure Support +4Pressure Support +6Pressure Support -2Pressure Support -4Pressure Support -6Pressure Support PMI=0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Mechanically ventilated in the ICU
  • Diagnosis of Acute Hypoxemic Respiratory Failure (AHRF)
  • Normocapnia or non-severe hypercapnia
  • Receiving Pressure Support Ventilation (PSV) for at least 24-72 hours
  • Presence of an arterial line for blood gas sampling

You may not qualify if:

  • Age \< 18 years
  • Known neurological or neuromuscular disorders affecting diaphragm function
  • Chronic Obstructive Pulmonary Disease (COPD) or hypercapnic respiratory failure
  • Psychomotor agitation or inadequate sedation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Santa Chiara Hospital, Trento, Trentino-Alto Adige, Italy

Trento, Trento, 38122, Italy

RECRUITING

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized Cross-over
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor Giacomo Bellani

Study Record Dates

First Submitted

March 11, 2025

First Posted

April 10, 2025

Study Start

October 8, 2025

Primary Completion (Estimated)

April 8, 2027

Study Completion (Estimated)

April 8, 2027

Last Updated

February 3, 2026

Record last verified: 2026-01

Locations